Yuki Nakamura

Saitama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

C-reactive protein at pembrolizumab initiation and its trajectory from first-line chemotherapy as prognostic markers in metastatic urothelial carcinoma (YUSHIMA study).

C-reactive protein at pembrolizumab initiation and its trajectory from first-line chemotherapy as prognostic markers in metastatic urothelial carcinoma (YUSHIMA study).

Journal: International urology and nephrology

Published: July 14, 2026

Real-world insights from comprehensive genomic profiling in patients with metastatic castration-resistant prostate cancer.

Real-world insights from comprehensive genomic profiling in patients with metastatic castration-resistant prostate cancer.

Journal: Japanese journal of clinical oncology

Published: January 22, 2026

Real-World Comparison of Triplet Versus Doublet Therapy in Japanese Patients With High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Propensity-Weighted Analysis From the YUSHIMA Registry and Exploratory Bayesian Evidence Synthesis.

Real-World Comparison of Triplet Versus Doublet Therapy in Japanese Patients With High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Propensity-Weighted Analysis From the YUSHIMA Registry and Exploratory Bayesian Evidence Synthesis.

Journal: The Prostate

Published: December 25, 2025

A truncated TNS3 isoform expressed in metastatic triple negative breast cancer stabilizes FAK and promotes lung metastasis.

A truncated TNS3 isoform expressed in metastatic triple negative breast cancer stabilizes FAK and promotes lung metastasis.

Journal: Oncogene

Published: December 21, 2025

Prognostic Significance of Hypoalbuminemia in Maintenance Avelumab Therapy After First-Line Chemotherapy for Metastatic Urothelial Carcinoma: A Multicenter Real-World Study (YUSHIMA Study).

Prognostic Significance of Hypoalbuminemia in Maintenance Avelumab Therapy After First-Line Chemotherapy for Metastatic Urothelial Carcinoma: A Multicenter Real-World Study (YUSHIMA Study).

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: December 16, 2025

Real-world efficacy of enfortumab vedotin in Japanese patients with metastatic urothelial carcinoma stratified by EV-301 trial eligibility: a multicenter Bayesian restricted mean survival time analysis.

Real-world efficacy of enfortumab vedotin in Japanese patients with metastatic urothelial carcinoma stratified by EV-301 trial eligibility: a multicenter Bayesian restricted mean survival time analysis.

Journal: Japanese journal of clinical oncology

Published: November 19, 2025

Performance of Prognostic Models in Patients With Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin After Platinum-Based Chemotherapy and Immune Checkpoint Inhibitors: YUSHIMA Study.

Performance of Prognostic Models in Patients With Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin After Platinum-Based Chemotherapy and Immune Checkpoint Inhibitors: YUSHIMA Study.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: October 01, 2025

Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges.

Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges.

Journal: Cancer research communications

Published: September 25, 2025

Impact of Impaired Renal Function on the Efficacy and Safety of Enfortumab Vedotin Monotherapy in a Multicenter Real-World Cohort of Patients With Metastatic Urothelial Cancer: YUSHIMA Study.

Impact of Impaired Renal Function on the Efficacy and Safety of Enfortumab Vedotin Monotherapy in a Multicenter Real-World Cohort of Patients With Metastatic Urothelial Cancer: YUSHIMA Study.

Journal: Clinical genitourinary cancer

Published: July 29, 2025

Author Correction: Immune evasion through mitochondrial transfer in the tumour microenvironment.

Author Correction: Immune evasion through mitochondrial transfer in the tumour microenvironment.

Journal: Nature

Published: July 27, 2025

Local Excision of a 5-cm Rectal Gastrointestinal Stromal Tumor Using Transanal Minimally Invasive Surgery (TAMIS): A Case Report.

Local Excision of a 5-cm Rectal Gastrointestinal Stromal Tumor Using Transanal Minimally Invasive Surgery (TAMIS): A Case Report.

Journal: Asian journal of endoscopic surgery

Published: June 29, 2025

Incidence of Low-risk Upper Tract Urothelial Carcinoma in Candidates for Kidney-sparing Surgery.

Incidence of Low-risk Upper Tract Urothelial Carcinoma in Candidates for Kidney-sparing Surgery.

Journal: Anticancer research

Published: June 03, 2025

Showing 1-12 of 34

Last Updated: 09/26/2026